Felicity Homested PharmD, MBA

Chief Executive Officer, FQHC 340B Compliance

Felicity Homsted is Chief Executive Officer for FQHC 340B Compliance Inc. In this role, she works with health centers and hospitals across the country to manage and improve their 340B and pharmacy programs. Dr. Homsted is also a Lead Investigator for the National Institute on Drug Abuse- Clinical Trials Network Research Study CTN-0116: Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder (PharmICO). Dr. Homsted’s specific professional interests are advancing primary care pharmacist integrations of pharmacists and healthcare advocacy. From 2012 to 2018, Dr. Homsted was Chief Pharmacy Officer for Penobscot Community Health Center Inc. (PCHC), Maine’s largest Federally Qualified Health Center. She was responsible for the administration of four pharmacies, integrated pharmacy services and PCHC’s two accredited pharmacy residency programs. She served as subject matter expert for the Apexus 340B Prime Vendor Program and faculty member for Apexus 340B University and has co-authored Apexus 340B Operations Certificate modules.